Financials data is unavailable for this security.
View more
Year on year Rhythm Biosciences Ltd had revenues fall -77.10% from 228.27k to 52.28k, though the company grew net income from a loss of 8.22m to a smaller loss of 6.86m.
Gross margin | -4,946.29% |
---|---|
Net profit margin | -13,115.47% |
Operating margin | -16,342.31% |
Return on assets | -148.83% |
---|---|
Return on equity | -203.42% |
Return on investment | -199.13% |
More ▼
Cash flow in AUDView more
In 2024, cash reserves at Rhythm Biosciences Ltd fell by 3.41m. Cash Flow from Financing totalled 2.80m or 5,364.90% of revenues. In addition the company used 6.14m for operations while cash used for investing totalled 82.28k.
Cash flow per share | -0.0292 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.0035 |
---|---|
Tangible book value per share | 0.0021 |
More ▼
Balance sheet in AUDView more
Current ratio | 1.58 |
---|---|
Quick ratio | 1.58 |
Total debt/total equity | 0.1889 |
---|---|
Total debt/total capital | 0.1589 |
More ▼